SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
0.3400
+0.0260 (8.28%)
At close: Dec 2, 2025, 4:00 PM EST
0.3399
-0.0001 (-0.03%)
After-hours: Dec 2, 2025, 4:18 PM EST
SeaStar Medical Holding Revenue
SeaStar Medical Holding had revenue of $183.00K in the quarter ending September 30, 2025, with 169.12% growth. This brings the company's revenue in the last twelve months to $881.00K, up 1,195.59% year-over-year. In the year 2024, SeaStar Medical Holding had annual revenue of $135.00K.
Revenue (ttm)
$881.00K
Revenue Growth
+1,195.59%
P/S Ratio
4.59
Revenue / Employee
$46,368
Employees
19
Market Cap
12.26M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 135.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
ICU News
- 8 hours ago - SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI - GlobeNewsWire
- 12 days ago - SeaStar Medical to Present at Upcoming NobleCon21 Investor Conference - GlobeNewsWire
- 15 days ago - SeaStar Medical Announces Appointment of Michael Messinger as CFO - GlobeNewsWire
- 19 days ago - SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 27 days ago - SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025 - GlobeNewsWire
- 2 months ago - SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children - GlobeNewsWire
- 2 months ago - SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury - GlobeNewsWire
- 2 months ago - SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children - GlobeNewsWire